what are the sensitivities of different cml therapies to various mutations including t315i?
Published 8 years ago • 132 plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
17:31
debate: chronic-phase cml patient develops a t315i mutation - experimental therapy
-
3:03
what are the recommendations for monitoring a mutation analysis in cml?
-
3:02
what is the definition of chronic-phase cml?
-
3:46
cml: rationale for mutation testing and tki therapy
-
1:59
comparing frontline therapies for the treatment of chronic myeloid leukemia
-
6:51
resistance to targeted-tki treatment in patients with cml
-
41:06
global perspectives | evolution of cml treatment and managing adverse events
-
1:17
the evolution of frontline treatment for cll: from chemoimmunotherapy to targeted agents
-
17:38
debate: chronic-phase cml patient develops a t315i mutation - transplant
-
9:33
detecting cml (chronic myeloid leukemia) w/ digital pcr | #labchat
-
6:02
treatment choice in cml
-
27:29
cml basics, new treatments, & what to do
-
5:07
case 2: ponatinib for t315i-mutated cml
-
4:42
chronic myeloid leukemia (cml) - treatment - tyrosine kinase (tk) inhibitors
-
4:16
cml & your genes
-
21:14
cml molecular monitoring: practical advice
-
7:49
mutation analysis in chronic myeloid leukemia (cml)
-
8:00
when to switch therapy in chronic myeloid leukemia
-
2:45
understanding the cause of tki resistance to improve management strategies in cml